ZNF416 utilize a variety of intracellular signaling pathways to modulate its activity. Forskolin, by directly activating adenylyl cyclase, increases the levels of cAMP within the cell, which in turn activates the cAMP response element-binding protein (CREB). Activated CREB can then facilitate the transcription and subsequent functional activation of ZNF416. Similarly, Isoproterenol, through its action as a beta-adrenergic agonist, also elevates cAMP levels, thereby utilizing the same pathway to potentially affect ZNF416. Moreover, Dibutyryl-cAMP, a cAMP analog, bypasses cell surface receptors and directly stimulates cAMP-dependent pathways, offering another route to ZNF416 activation. In contrast, Phorbol 12-myristate 13-acetate (PMA) and TPA (12-O-Tetradecanoylphorbol-13-acetate), through their role as activators of protein kinase C (PKC), enhance the phosphorylation of a range of proteins, including those that can modulate ZNF416 activity.
Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent signaling pathways, such as those mediated by calmodulin-dependent kinase (CaMK), which may phosphorylate regulatory proteins that influence ZNF416 activation. EGF, through the activation of the EGF receptor, triggers the MAPK/ERK signaling cascade, which includes a series of protein kinases capable of modifying transcription factors that regulate ZNF416. Insulin, via the insulin receptor, initiates the PI3K/Akt pathway, where Akt kinase can phosphorylate various substrates to affect ZNF416. Anisomycin, while inhibiting protein synthesis, concurrently activates MAPK/ERK and JNK pathways that can lead to enhanced phosphorylation and activation of proteins associated with ZNF416. Calyculin A and Okadaic Acid, as inhibitors of protein phosphatases PP1 and PP2A, result in increased phosphorylation levels of proteins, which can, in turn, influence the activation state of ZNF416. Lastly, Brefeldin A disrupts the Golgi apparatus, which can impact protein trafficking and signaling mechanisms, possibly leading to altered regulation and activation of ZNF416. Each chemical, through its unique mechanism, can influence the phosphorylation state, transcriptional activity, or protein interaction networks surrounding ZNF416, thereby modulating its functional state within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of protein targets potentially including transcription factors that regulate the activity of ZNF416. Activation of PKC therefore leads to changes in the phosphorylation status of proteins involved in ZNF416's functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore for calcium, increasing intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways include calmodulin-dependent kinase (CaMK), which could phosphorylate transcription factors or other proteins that influence ZNF416 activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor leading to the activation of the PI3K/Akt signaling pathway. Akt can phosphorylate and activate various proteins including transcription factors that can enhance the functional activity of ZNF416. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase via G protein-coupled receptor signaling, increasing cAMP levels. This activation of the cAMP pathway can lead to the activation of transcription factors that regulate ZNF416 activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation of proteins. This can enhance the phosphorylation state of proteins that are responsible for ZNF416 activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates the MAPK/ERK and JNK pathways, potentially increasing the phosphorylation of transcription factors or other regulatory proteins that could activate ZNF416. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that activates cAMP-dependent pathways, which can lead to the activation of transcription factors or other proteins that are part of ZNF416's activation process. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased protein phosphorylation. Elevated phosphorylation levels could promote the activation of proteins involved in ZNF416's functional activation pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein trafficking by inhibiting the function of the Golgi apparatus, which can influence signaling pathways and lead to the activation of transcription factors or other proteins involved in the functional activation of ZNF416. | ||||||